Comments on: 166 Reportable Adverse Events Equals One Red Herring http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-red-herring/ A Healthy Approach to E-marketing -- Effectively using digital technology and social media in pharma and healthcare marketing Fri, 12 Mar 2010 14:35:27 +0000 http://wordpress.org/?v=2.9.1 hourly 1 By: Top three reasons why Biotech Companies should use Social Media « The RIC Blog http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-red-herring/#comment-3556 Top three reasons why Biotech Companies should use Social Media « The RIC Blog Thu, 17 Dec 2009 11:28:28 +0000 http://www.doseofdigital.com/?p=1716#comment-3556 [...] [...] [...] [...]

]]> By: Biotech Trends in 2010: Top Three Reasons Why Biotech Companies Should Use Social Media « The Cross-Border Biotech Blog http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-red-herring/#comment-3442 Biotech Trends in 2010: Top Three Reasons Why Biotech Companies Should Use Social Media « The Cross-Border Biotech Blog Wed, 09 Dec 2009 20:51:18 +0000 http://www.doseofdigital.com/?p=1716#comment-3442 [...] [...] [...] [...]

]]> By: Jonathan Richman http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-red-herring/#comment-3085 Jonathan Richman Wed, 11 Nov 2009 16:16:34 +0000 http://www.doseofdigital.com/?p=1716#comment-3085 Thanks, Marian. I'd love if every LMR team had to read this. I'm in agreement with you on the idea that adverse events aren't the real (or only) reason many companies are dragging their heels, but it's certainly the most common excuse (for lack of a better word). I'm hoping to put this one aside and get down into the real reasons why. I'll consider the byline piece, but many pubs don't want anything if it's been published elsewhere (everyone wants an "exclusive"). I generally don't do these though. The mini white paper thing was someone else's idea who noted that many of my posts were long and involved enough to be white papers. Many are much more than an average blog post (whatever that is). So, without blowing everything out into a full white paper (complete with fancy layouts), this is what I've gone with. If you click the icon, you'll see all of the posts I've dubbed "Mini White Papers." You can also follow this link: http://www.doseofdigital.com/mini-white-paper Thanks, Marian. I’d love if every LMR team had to read this. I’m in agreement with you on the idea that adverse events aren’t the real (or only) reason many companies are dragging their heels, but it’s certainly the most common excuse (for lack of a better word). I’m hoping to put this one aside and get down into the real reasons why. I’ll consider the byline piece, but many pubs don’t want anything if it’s been published elsewhere (everyone wants an “exclusive”). I generally don’t do these though.

The mini white paper thing was someone else’s idea who noted that many of my posts were long and involved enough to be white papers. Many are much more than an average blog post (whatever that is). So, without blowing everything out into a full white paper (complete with fancy layouts), this is what I’ve gone with. If you click the icon, you’ll see all of the posts I’ve dubbed “Mini White Papers.” You can also follow this link: http://www.doseofdigital.com/mini-white-paper

]]> By: mariancutler http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-red-herring/#comment-3083 mariancutler Wed, 11 Nov 2009 14:58:15 +0000 http://www.doseofdigital.com/?p=1716#comment-3083 This should be required reading for all LMR teams within every pharmaceutical and biotech entity out there. As much as I remain unconvinced that AEs are the real reason for many companies to drag their heels in embracing social media, this provides a foundation of consistent understanding currently missing within the space. Appreciating you've dubbed this a "mini white paper" may I suggest you work on crafting it into a bylined article for reprinting in a couple of well-placed publications? Solid work. Kudos! Marian Cutler www.twitter.com/mariancutler This should be required reading for all LMR teams within every pharmaceutical and biotech entity out there. As much as I remain unconvinced that AEs are the real reason for many companies to drag their heels in embracing social media, this provides a foundation of consistent understanding currently missing within the space. Appreciating you’ve dubbed this a “mini white paper” may I suggest you work on crafting it into a bylined article for reprinting in a couple of well-placed publications? Solid work. Kudos!

Marian Cutler
http://www.twitter.com/mariancutler

]]> By: Jonathan Richman http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-red-herring/#comment-3081 Jonathan Richman Wed, 11 Nov 2009 04:22:46 +0000 http://www.doseofdigital.com/?p=1716#comment-3081 I like it, John. So, what I'm hearing you say is that marketers don't need rules to make ineffective marketing, they can do it well enough on their own. Sound right? I like it, John. So, what I’m hearing you say is that marketers don’t need rules to make ineffective marketing, they can do it well enough on their own. Sound right?

]]> By: Varadh Krish http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-red-herring/#comment-3079 Varadh Krish Wed, 11 Nov 2009 03:41:05 +0000 http://www.doseofdigital.com/?p=1716#comment-3079 Good Post. Helps in analyzing the issue of whether it is worth holding back. Great perspective analysis with a fundamental attempt on quantification. Good Post. Helps in analyzing the issue of whether it is worth holding back. Great perspective analysis with a fundamental attempt on quantification.

]]>